Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Electronic medication reconciliation · 1 trial · 1 indication
Number and fraction of outpatient medications prescribed or addressed as to why prescribing did not occur. Number and fraction of cases with MR by a pharmacist. Number and fraction of cases undergoing any MR. Number and fraction of cases where any outpatient medications were not prescribed or addressed as to why prescribing did not occur.
| Arm | Type | Description |
|---|---|---|
| Electronic medication reconciliation | EXPERIMENTAL | Providers have access to a new, computer-based application to facilitate documentation and prescribing of outpatient medications in the inpatient setting. |
| Control | NO_INTERVENTION | - |
| Name | Type | Description |
|---|---|---|
| Electronic medication reconciliation | OTHER | A new, computer-based application will be used to document and prescribe outpatient medications in the inpatient setting. |
Inclusion Criteria: * Patients admitted to the Medicine Service during a 12-month period * Physicians who provide inpatient or ambulatory care for participating patients. * Pharmacists who provide care for participating patients. Exclusion Criteria: * Patients admitted but not seen in a primary-c...
Electronic medication reconciliation is used for medication reconciliation, the process of comparing a patient's medication orders to all of the medications the patient has been taking. It is designed to improve the quality of transitional care, which is the coordination and continuity of health care during movement between different health care settings.
Electronic medication reconciliation is developed by Healthcare Services Group, a company traded on the NASDAQ under the ticker HCSG. The company is conducting clinical development of this medication reconciliation technology.
Electronic medication reconciliation is in Phase 3 clinical development. It is an investigational technology and is not approved for commercial use. The Phase 3 trial has been completed, and the technology is being evaluated for its effectiveness in improving transitional care.
Electronic medication reconciliation has one completed Phase 3 clinical trial, identified as NCT01195051, titled "Medication Reconciliation Technology to Improve Quality of Transitional Care." The trial enrolled 4,818 participants in the United States, with a minimum age of 18 years, and included both male and female participants.
Yes, the Phase 3 clinical trial of Electronic medication reconciliation, NCT01195051, is a randomized trial. It is not double-blind and uses a no-treatment control group. The trial enrolled 4,818 participants and has been completed.